Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA


Posted on: 24 Aug 18
Date on which the terms and conditions of the preferential rights issue were announced:  24 august 2018
Last day including right: 14 September 2018
Ex-date: 17 September 2018
Record Date: 18 September 2018
Date of approval: 14 September 2018
Maximum number of new shares: 12,000,000
Subscription price: 30
Will the rights be listed: yes
 

This information is published in accordance with the requirements of the Continuing Obligations.

GlobeNewswire
globenewswire.com

Last updated on: 24/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.